Search results for "Anticoagulant therapy"
Vitamin K antagonists provide benefit in elderly patients with afib, study finds
Patients older than 75 who have atrial fibrillation benefited from vitamin K antagonist therapy, although their risks for stroke and bleeding were higher than in younger patients, a recent study found.
https://acphospitalist.acponline.org/weekly/archives/2014/12/10/3.htm
10 Dec 2014
MKSAP quiz on pulmonary embolism
This month's quiz includes questions from ACP's Medical Knowledge Self-Assessment Program (MKSAP 18) on pulmonary embolism.
https://acphospitalist.acponline.org/archives/2020/06/mksap-quiz-on-pulmonary-embolism.htm
15 Jun 2020
Patients with superficial vein thrombosis may also have DVT
Proposed updates for DSM-5 released
https://acphospitalist.acponline.org/weekly/archives/2010/02/17/3.htm
17 Feb 2010
Higher-dose prophylactic anticoagulation required to prevent thrombosis in hypoxemic COVID-19
Mortality and time to improvement didn't differ with twice the standard dose of heparin versus a standard or therapeutic dose, but there was a lower rate of new thromboembolic events with no increase in major bleeding, a French trial found.
https://acphospitalist.acponline.org/archives/2023/03/29/free/higher-dose-prophylactic-anticoagulation-needed-to-prevent-thrombosis-in-hypoxemic-covid-19.htm
29 Mar 2023
Focused update released on management of unstable angina, non-ST-segment- elevation MI
The American College of Cardiology Foundation/American Heart Association released a focused update last week to their guidelines on management of unstable angina and non-ST-segment-elevation myocardial infarction (NSTEMI).
https://acphospitalist.acponline.org/weekly/archives/2012/07/25/5.htm
25 Jul 2012
Risk for DVT, PE, bleeding after COVID-19, but low long-term VTE recurrence risk
One study found increased risk for deep venous thrombosis (DVT) for up to three months after COVID-19, pulmonary embolism (PE) for up to six months, and bleeding for up to two months, while another showed low rates of venous thromboembolism (VTE) recurrence in the year after infection.
https://acphospitalist.acponline.org/archives/2022/04/13/free/risk-for-dvt-pe-bleeding-seen-after-covid-19-long-term-risk-for-vte-recurrence-may-be-low.htm
13 Apr 2022
Moderate VTE risk exists after cerebral vein and dural sinus thrombosis
AIDS society updates antiretroviral recommendations for U.S. adults
https://acphospitalist.acponline.org/weekly/archives/2010/07/28/3.htm
28 Jul 2010
Recent Research
HIV screening recommendations, perioperative SSRI risks, anticoagulants and endocarditis, and more.
https://acphospitalist.acponline.org/archives/2013/07/rr.htm
15 Jul 2013
New recommendations for VTE
The Joint American College of Physicians/American Academy of Family Physicians Panel on Deep Venous Thrombosis/Pulmonary Embolism recently released new recommendations for treatment and diagnosis of venous thromboembolism.
https://acphospitalist.acponline.org/archives/2007/05/vte.htm
15 May 2007
Adding P2Y12 inhibitor to heparin offered no benefit in non-critically ill COVID-19 inpatients
An open-label randomized trial at 60 hospitals in four countries found no increase in organ support-free days in patients who received a therapeutic dose of heparin plus a P2Y12 inhibitor versus heparin alone.
https://acphospitalist.acponline.org/archives/2022/01/19/free/adding-P2Y12-inhibitor-to-heparin-offered-no-benefit.htm
19 Jan 2022